IVIG-L

DRUG2 trials

Sponsors

Prothya Biosolutions

Conditions

HypogammaglobulinemiaPurpura, Thrombocytopenic, Idiopathic

Phase 2

Kinetics, Efficacy and Safety of IVIG-L in Hypogammaglobulinemia Patients

CompletedNCT00138697

Prothya BiosolutionsHypogammaglobulinemia

Start: 2001-05-31End: 2004-12-31Target: 15Updated: 2007-04-19

Phase 3

Efficacy and Safety of IVIG-L in ITP Patients

CompletedNCT00151840

Prothya BiosolutionsPurpura, Thrombocytopenic, Idiopathic

Start: 2001-10-31End: 2002-03-31Target: 20Updated: 2006-01-31